
Overview
Poltiss is a company that develops PhotoBioCure™ technology, which utilizes biopolymers that transform from a sticky liquid to flexible solids under UV radiation to create customized, biodegradable implants for tissue defects. Their biomaterials are designed for minimally invasive surgical procedures, eliminating the need for sutures and facilitating tissue regeneration. Founded in 2015, Poltiss focuses on improving the comfort of patients and surgeons through their programmable biopolymers.
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 77 days for 2021).
- 202520/07/2026
- 202409/06/2025
- 202312/09/2024
- 202212/06/2023
- 202130/09/2022
- 202023/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
If one person is appointed to the management board, the company shall be represented by one member of the management board independently; if more than one person is appointed to the management board, the company shall be represented by two members of the management board acting jointly or by a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 54 | $729.34 | 25.2336% | |
Mirosława Helena El Fray age 61 | 95 | $1,283.09 | 44.3925% |
Tomasz Jacek Łasecki age 46 | 51 | $688.82 | 23.8318% |
Others | 14 | $189.09 | 6.5421% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-03-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
7 public aid cases recorded, with a total value of $646,802.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 20, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,142$2,142 | Marszałek Województwa Zachodniopomorskiego | |
| Apr 6, 2021 | Aid for research and development projects: industrial research | $112.8K$112,779 | Marszałek Województwa Zachodniopomorskiego | |
| Apr 6, 2021 | Aid for research and development projects: experimental development | $38,047$38,047 | Marszałek Województwa Zachodniopomorskiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-05-01 | Development of new functionalities for PhotoBioCure technology and clinical testing of its safety and efficacy. | $165.5K$165,533 | Regional Operational Programme of the Zachodniopomorskie Voivodeship 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Stenocoat sp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bonereg sp. z o.o. | $25,113.01 | bonereg.com | ||
| Arthec S.A. | $10,911.16 | arthec.eu | ||
| Thesybin Labs P.S.A. | $8,297.34 | thesybin.pl | ||
| Oncotherics Poland S.A. | $7,565.33 | oncotherics.com | ||
| Fusiomica sp. z o.o. | $5,263.98 | fusiomica.com | ||
| Centrum Inżynierii Niekonwencjonalnej sp. z o.o. | $5,023.18 | niekonwencjonalna.pl | ||
| Spinbionic sp. z o.o. | $3,516.36 | spinbionic.com | ||
| Refoldit sp. z o.o. | $2,586.64 | refoldit.com | ||
| BIO Science Centrum Badań Doświadczalnych sp. z o.o. | $1,557.01 | biosciencelublin.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-20 | Share capital increase (10,600.00 PLN → 10,700.00 PLN) | |
| 2021-10-04 | Address change (Al. Piastów 45/1/38, 71-311, Szczecin → Al. Wojska Polskiego 150/1, 71-324, Szczecin) | |
| 2021-06-29 | Share capital increase (10,060.00 PLN → 10,600.00 PLN) | |
| 2021-05-31 | Share capital increase (10,000.00 PLN → 10,060.00 PLN) | |
| 2018-07-30 | Address change (Ul. Jagiellońska 20-21, 70-363, Szczecin → Al. Piastów 45/1/38, 71-311, Szczecin) |
FAQ
Last updated: 2026-07-20
